MTMarc Töteberg-Harms

Marc Töteberg-Harms

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc Töteberg-Harms has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Belgin Vasella

    University of Zurich and University Hospital Zurich

    2 shared publications
  • Alexander von Vopelius-Feldt

    Ophthalmology, University Hospital Zurich, Switzerland

    1 shared publication
  • Andreas Mayr

    Institute for Medical Biometry and Statistics, Philipps-University-Marburg, Germany

    1 shared publication
  • Danny Alevy

    Medical College of Georgia, Department of Ophthalmology, Augusta University, Augusta, USA

    1 shared publication
  • Haley Chishom

    Medical College of Georgia, Department of Ophthalmology, Augusta University, Augusta, USA

    1 shared publication
  • Mathilde Franklin

    Medical College of Georgia, Department of Ophthalmology, Augusta University, Augusta, USA

    1 shared publication

Latest Publications

  • Open Access

    The impact of treatment modality on quality of life in glaucoma patients: findings from a clinical survey study in Augusta, GA

    by Neel Edupuganti, Haley Chishom, Tommy Bui, Danny Alevy, Tae Jin Lee, Mathilde Franklin, Marc Töteberg-Harms

    Purpose: This study evaluates the impact of medical versus combined medical and surgical glaucoma treatments on patients’ quality of life (QoL). While both approaches reduce intraocular pressure, research shows mixed effects on QoL. Given updated clinical guidelines and the gap in QoL-focused glaucoma management, this study applies validated QoL measures to assess treatment effects and inform patient-centered care. Methods: From June to October 2023, 180 patients at Augusta University Eye Care Center completed the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and Glaucoma Profile Instrument (GPI) surveys. Chart reviews provided demographic and clinical data, including glaucoma status and treatment. QoL scores were calculated using validated algorithms. Associations between clinical variables and QoL outcomes were analyzed using ANOVA and t-tests in R 4.4.1. Results: Among 180 patients, 103 had glaucoma or were suspects. 64% of glaucoma patients received medical treatment only, and 34% received combined medical and surgical treatment. VFQ-25 scores differed significantly by race ( p = 0.0489), severity ( p = 0.0001), and age ( p = 0.0459), but not by gender, glaucoma status, or treatment. Severe glaucoma patients had the lowest QoL. Severity strongly impacted GPI scores ( p = 0.0092) and multiple VFQ-25 domains. Differences by treatment modality were observed only in the driving subscale ( p = 0.0378). No significant differences were observed in overall QoL scores between treatment groups. Conclusion: No significant vision-related QoL differences were found between treatment groups. Most patients were medically managed, possibly reflecting limited QoL benefit from surgery. QoL correlated more with disease severity than treatment modality or demographics. These findings highlight a disconnect between current treatment strategies and patient-perceived outcomes, underscoring the need for innovative strategies to improve QoL in glaucoma care.


  • Die Therapie des Normaldruckglaukoms

    by Belgin Vasella, Marc Töteberg-Harms

  • Evaluation of Reproducibility of Measurements of Peripapillary Blood Flow with Laser Speckle Flowgraphy in Healthy and POAG Subjects

    by Alexander von Vopelius-Feldt, Timothy Hamann, Andreas Mayr, Marc Töteberg-Harms

    Background Peripapillary blood flow is of diagnostic value in glaucoma. Material and Methods We investigated the reproducibility of peripapillary blood flow measurements in healthy individuals and in open-angle glaucoma (OAG) patients with the Nidek laser speckle flowgraphy (LSFG)-NAVI system. Blood flow was calculated as the mean of vascular area (MV), mean of tissue area (MT), and mean of overall flow (MA). Intra-rater, inter-session, and inter-rater reproducibility were assessed by determining the intraclass correlation coefficient (ICC) and coefficient of variance (COV). Results There were 28 healthy subjects and 16 patients with OAG who participated in this prospective single-center trial. ICC and COV of intra-rater reproducibility were assessed in MV as 0.901; 6.424, MT as 0.909; 4.025, and MA as 0.965; 4.168. Inter-session reproducibility yielded ICC and COV values of MV (0.834; 9.223), MT (0.904; 6.215), MA (0.909; 7.069). Inter-rater reproducibility was computed for MV as 0.78; 9.758, MT as 0.890; 7.210, and MA as 0.888; 6.942. There was a significant difference in MA (p = 0.0184) between the healthy individuals (mean 36.299) and the OAG group (mean 24.944), which was not observed for MV (p = 0.0735) or MT (p = 0.1351). Conclusion High reproducibility of measurements of peripapillary blood flow with the LSFG system was demonstrated in both groups. There is a difference in peripapillary blood flow between healthy controls and OAG patients.

  • Die Therapie des Normaldruckglaukoms

    by Belgin Vasella, Marc Töteberg-Harms